BioSpace News Archive

Business

Lexington Biosciences Announces Appointment of CEO

Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) is pleased to announce the appointment of Donald McInnes as chief executive officer of the Company, filing the vacancy left by the resignation of Eric Willis.

April 16, 2020
·
1 min read
Business

Teva to Host Conference Call to Discuss First Quarter 2020 Financial Results at 8 a.m. ET on May 7, 2020

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its first quarter financial results on Thursday, May 7, 2020 at 7:00 a.m. ET.

April 16, 2020
·
6 min read
BioCapital

Coronavirus (COVID-19) Update: FDA, Gates Foundation, UnitedHealth Group, Quantigen, and U.S. Cotton Collaborate to Address Testing Supply Needs

The U.S. Food and Drug Administration announced a further expansion of COVID-19 testing options through the recognition that spun synthetic swabs – with a design similar to Q-tips – could be used to test patients by collecting a sample from the front of the nose.

April 16, 2020
·
2 min read
Business

Eve & Co Announces Financial Results For The Year Ended December 31, 2019

Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce its financial results for the year ended December 31, 2019.

April 16, 2020
·
4 min read
BioMidwest

New Study Shows Effectiveness of Polyester Swabs and Saline Transportation for COVID-19 Testing, Improving Testing Efficiency and Flexibility, and Protecting Health Care Workers

A study led by UnitedHealth Group (NYSE: UNH) Research & Development and The Everett Clinic, part of Optum, revealed alternative swab materials and commonly available saline are effective for COVID-19 testing, providing more options for sample collection.

April 16, 2020
·
3 min read
Drug Development

MindMed Initiates Dosing in Human Safety Study of Novel Treatment for Opioid Addiction, 18-MC

Mind Medicine (MindMed) Inc. (NEO: MMED)(OTC: MMEDF), the leading psychedelic pharmaceutical company, has begun dosing the first subject in an additional Phase 1 human safety trial of 18-MC.

April 16, 2020
·
4 min read
Biotech Bay

Cutera, Inc. Announces Pricing of Public Offering of Common Stock

Cutera, Inc. (NASDAQ: CUTR) (“Cutera”), a provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced the pricing of an underwritten public offering of 2,385,000 shares of its common stock at a public offering price of $10.50 per share.

April 16, 2020
·
3 min read
BioMidwest

Kraig Biocraft Laboratories achieves Knock-in Knock-out Success to create nearly Pure Spider Silk

Kraig Biocraft Laboratories, Inc., the leading developer of spider silk based fibers, announced, at a press conference held after today’s market close, that it successfully developed a new technology platform, based on a non-CRISPR gene editing knock-in knock-out technology.

April 16, 2020
·
3 min read